ロード中...
Engineering Escherichia coli for Soluble Expression and Single Step Purification of Active Human Lysozyme
Genetically engineered variants of human lysozyme represent promising leads in the battle against drug-resistant bacterial pathogens, but early stage development and testing of novel lysozyme variants is constrained by the lack of a robust, scalable and facile expression system. While wild type huma...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3594478/ https://ncbi.nlm.nih.gov/pubmed/23220215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbiotec.2012.11.007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|